Complete Filing Data
Cardio Diagnostics Holdings, Inc. reported Stockholders Equity of $6.97 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cardio Diagnostics Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$6.5M | -$8.4M | -$8.4M | -$4.7M | -$620.4K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.5M | -$8.4M | -$8.4M | -$4.7M | -$620.4K |
| Operating Income Loss | -$6.5M | -$8.4M | -$7.2M | -$4.5M | -$620.4K |
| Operating Expenses | $6.5M | $8.4M | $7.3M | $4.5M | $621.3K |
| Revenues | $14.8K | $34.9K | $17.1K | $950.00 | $901.00 |
| Other Nonoperating Income Expense | -$14.1K | -$17.6K | -$1.1M | -$112.5K | |
| Interest Expense | $14.8K | $18.6K | $6.7M | ||
| Selling And Marketing Expense | $766.9K | $1.2M | $158.5K | $92.7K | $103.3K |
| General And Administrative Expense | $5.0M | $6.9M | $6.9M | $4.4M | $470.6K |
| Research And Development Expense | $641.2K | $228.0K | $145.2K | $40.4K | $31.5K |
| Income Tax Expense Benefit | $0.00 | $0.00 | |||
| Net Income Loss Available To Common Stockholders Basic | $4.7M | $620.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.7M | -$1.7M | -$1.6M | -$1.4M | -$1.3M | -$4.2M | -$1.9M | -$4.0M | -$1.0M | -$1.2M | -$842.0K | -$290.1K | -$721.00 | -$397.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.7M | -$1.7M | -$1.6M | -$1.4M | -$1.3M | -$4.2M | -$1.9M | -$4.0M | -$1.0M | -$1.2M | -$842.0K | -$290.1K | -$721.00 | -$397.00 |
| Operating Income Loss | -$1.7M | -$1.7M | -$1.6M | -$1.4M | -$1.3M | -$4.2M | -$1.4M | -$2.6M | -$1.7M | -$1.2M | -$787.0K | -$227.1K | -$721.00 | -$397.00 |
| Operating Expenses | $1.7M | $1.7M | $1.6M | $1.4M | $1.3M | $4.2M | $1.5M | $2.6M | $1.7M | $1.2M | $787.0K | $232.6K | ||
| Revenues | $2.9K | $7.5K | $940.00 | $6.6K | $7.9K | $15.9K | $10.0K | $1.7K | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Other Nonoperating Income Expense | -$2.9K | -$4.5K | -$4.5K | -$3.6K | -$5.5K | -$5.5K | -$488.2K | -$1.5M | $670.5K | $0.00 | -$55.0K | -$57.5K | ||
| Interest Expense | $3.1K | $4.7K | $4.7K | $3.9K | $5.8K | $5.8K | $570.4K | $1.1M | $5.0M | $0.00 | $0.00 | |||
| Selling And Marketing Expense | $41.8K | $52.1K | $57.8K | $34.4K | $34.1K | $31.6K | $49.6K | $16.4K | $26.8K | $22.4K | ||||
| General And Administrative Expense | $1.5M | $1.4M | $1.2M | $4.1M | $1.4M | $2.5M | $1.6M | $1.1M | $751.1K | $205.0K | ||||
| Research And Development Expense | $2.2K | $5.2K | $7.3K | $10.8K | $38.7K | $12.3K | $86.7K | $3.2K | $5.0K | $1.1K | ||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Net Income Loss Available To Common Stockholders Basic | $1.0M | $290.1K | -$721.00 | -$397.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $7.0M | $9.6M | $3.0M | $4.3M | $1.1M | $60.4K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.1M | $7.8M | $1.3M | $4.1M | $512.8K | $237.1K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$2.7M | $6.5M | -$2.8M | $3.6M | $275.7K | |
| Retained Earnings Accumulated Deficit | -$29.3M | -$22.8M | -$14.4M | -$6.0M | -$1.3M | |
| Liabilities And Stockholders Equity | $7.8M | $10.6M | $4.5M | $6.2M | $1.1M | |
| Liabilities | $793.1K | $1.1M | $1.5M | $1.9M | $33.9K | |
| Assets Current | $5.9M | $8.8M | $2.8M | $5.9M | $803.5K | |
| Assets | $7.8M | $10.6M | $4.5M | $6.2M | $1.1M | |
| Common Stock Value | $18.00 | $15.00 | $205.00 | $95.00 | ||
| Liabilities Current | $604.8K | $631.7K | $841.1K | $1.9M | ||
| Prepaid Expense And Other Assets Current | $801.9K | $944.7K | $1.5M | $1.8M | $39.8K | |
| Other Intangible Assets Net | $873.2K | $701.1K | $515.4K | $321.3K | $245.2K | |
| Finance Agreement Payable | $269.8K | $306.8K | $374.0K | $849.0K | $0.00 | |
| Deposits Assets Noncurrent | $12.9K | $12.9K | $12.9K | $5.0K | $0.00 | |
| Accounts Payable And Accrued Liabilities Current | $97.4K | $87.7K | $243.2K | $1.1M | $33.9K | |
| Finite Lived Intangible Assets Net | $5.3K | $21.3K | $37.3K | $53.3K | ||
| Accounts Receivable Net Current | $8.1K | $18.6K | $5.0K | $901.00 | ||
| Operating Lease Right Of Use Asset | $259.6K | $432.4K | $575.2K | |||
| Marketable Securities Gain Loss | ||||||
| Property Plant And Equipment Net | $700.1K | $672.9K | $571.9K | |||
| Operating Lease Liability Current | $237.6K | $237.3K | $223.9K | |||
| Liabilities Noncurrent | $188.2K | $425.8K | $663.1K | |||
| Preferred Stock Value | $0.00 | |||||
| Change In Fair Value Of Derivative Liability | $5.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $8.2M | $9.7M | $11.4M | $3.7M | $3.1M | $3.0M | $2.3M | $2.9M | $3.4M | $9.6M | $9.7M | $778.1K | $24.3K | $24.6K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.4M | $8.0M | $9.7M | $2.0M | $1.3M | $1.6M | $3.6M | $5.0M | $6.7M | $9.0M | $9.7M | $310.2K | $9.7K | $34.3K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.9M | $279.6K | $2.6M | -$202.5K | $9.7K | $34.3K | ||||||||||
| Retained Earnings Accumulated Deficit | -$27.8M | -$26.1M | -$24.4M | -$21.2M | -$19.8M | -$18.5M | -$13.0M | -$11.0M | -$7.0M | -$747.9K | -$860.2K | -$367.5K | ||||
| Liabilities And Stockholders Equity | $8.8M | $10.4M | $12.3M | $4.5M | $4.0M | $4.3M | $6.0M | $6.8M | $8.6M | $65.8M | $65.2M | $65.6M | ||||
| Liabilities | $637.3K | $671.8K | $905.0K | $795.3K | $922.5K | $1.3M | $3.7M | $3.8M | $5.1M | $631.7K | $229.4K | $180.5K | ||||
| Assets Current | $6.9M | $8.7M | $10.5M | $2.6M | $2.1M | $2.6M | $4.5M | $6.3M | $8.1M | $228.1K | $186.1K | $635.7K | ||||
| Assets | $8.8M | $10.4M | $12.3M | $4.5M | $4.0M | $4.3M | $6.0M | $6.8M | $8.6M | $65.8M | $65.2M | $65.6M | ||||
| Common Stock Value | $18.00 | $17.00 | $17.00 | $303.00 | $233.00 | $216.00 | $131.00 | $112.00 | $96.00 | $16.00 | $16.00 | $16.00 | $16.00 | |||
| Liabilities Current | $398.4K | $369.6K | $540.6K | $308.7K | $376.1K | $685.7K | $3.0M | $631.7K | $229.4K | $180.5K | $124.4K | |||||
| Prepaid Expense And Other Assets Current | $561.0K | $723.9K | $837.2K | $630.5K | $820.9K | $1.0M | $892.3K | $1.2M | $1.4M | |||||||
| Other Intangible Assets Net | $800.5K | $711.1K | $701.3K | $651.5K | $596.9K | $564.6K | $486.3K | $434.0K | $373.2K | |||||||
| Finance Agreement Payable | $0.00 | $76.7K | $191.7K | $0.00 | $93.5K | $233.8K | $0.00 | $283.0K | $566.0K | |||||||
| Deposits Assets Noncurrent | $12.9K | $12.9K | $12.9K | $12.9K | $12.9K | $12.9K | $12.9K | $12.9K | $7.1K | |||||||
| Accounts Payable And Accrued Liabilities Current | $150.7K | $48.7K | $108.2K | $74.8K | $52.1K | $224.7K | $623.1K | $651.4K | $742.6K | |||||||
| Finite Lived Intangible Assets Net | $1.3K | $9.3K | $13.3K | $17.3K | $25.3K | $29.3K | $33.3K | |||||||||
| Accounts Receivable Net Current | $11.2K | $12.9K | $9.6K | $14.1K | $7.5K | $19.0K | $350.00 | $1.1K | $0.00 | |||||||
| Operating Lease Right Of Use Asset | $303.8K | $347.3K | $390.2K | $474.0K | $514.9K | $555.3K | $879.3K | |||||||||
| Marketable Securities Gain Loss | $367.4K | $5.8K | $4.4K | $0.00 | $0.00 | |||||||||||
| Property Plant And Equipment Net | $744.3K | $621.9K | $641.0K | $706.7K | $720.2K | $588.3K | $37.2K | $26.0K | $0.00 | |||||||
| Operating Lease Liability Current | $247.7K | $244.2K | $240.7K | $233.9K | $230.5K | $227.2K | $178.1K | $0.00 | ||||||||
| Liabilities Noncurrent | $238.9K | $302.3K | $364.4K | $486.6K | $546.4K | $605.1K | $720.5K | $0.00 | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Change In Fair Value Of Derivative Liability | -$31.0K | -$53.8K | $5.7M | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$5.7M | -$5.0M | -$5.7M | -$5.1M | -$585.3K |
| Net Cash Provided By Used In Financing Activities | $3.4M | $11.9M | $3.6M | $9.1M | $1.2M |
| Net Cash Provided By Used In Investing Activities | -$419.3K | -$404.2K | -$794.3K | -$368.0K | -$364.0K |
| Payments To Acquire Intangible Assets | $232.0K | $189.4K | $197.3K | $76.2K | $114.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $9.8K | -$155.6K | -$781.5K | $136.4K | -$5.7K |
| Increase Decrease In Accounts Receivable | -$10.5K | $13.7K | $5.0K | -$901.00 | $901.00 |
| Share Based Compensation | $110.2K | $2.6M | $1.3M | $0.00 | $60.0K |
| Payments To Acquire Finance Receivable | $374.2K | $450.7K | $942.5K | $188.7K | |
| Payments To Acquire Property Plant And Equipment | $187.3K | $214.8K | $575.7K | ||
| Payments Of Placement Agent Fee | $155.0K | $315.0K | $1.2M | $0.00 | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$480.0K | -$916.0K | -$758.7K | $690.8K | |
| Increase Decrease In Operating Lease Liability | -$237.3K | -$223.9K | $244.5K | ||
| Proceeds From Issuance Or Sale Of Equity | $3.8M | $12.4M | $12.0M | $105.0K | |
| Proceeds From Issuance Of Common Stock | $12.0M | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.4M | -$1.2M | -$1.6M | -$186.1K | -$174.00 | $0.00 |
| Net Cash Provided By Used In Financing Activities | $3.3M | $1.6M | $4.3M | $0.00 | $9.9K | $34.3K |
| Net Cash Provided By Used In Investing Activities | -$47.4K | -$69.9K | -$52.7K | -$16.4K | $0.00 | |
| Payments To Acquire Intangible Assets | $41.6K | $50.0K | $52.7K | $16.4K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $20.5K | -$18.5K | -$282.1K | $21.2K | ||
| Increase Decrease In Accounts Receivable | -$9.1K | $14.0K | $0.00 | -$901.00 | ||
| Share Based Compensation | $30.6K | $2.5M | $4.0K | $0.00 | ||
| Payments To Acquire Finance Receivable | $115.0K | $140.3K | $283.0K | |||
| Payments To Acquire Property Plant And Equipment | $5.8K | $20.0K | ||||
| Payments Of Placement Agent Fee | $155.0K | $315.0K | $0.00 | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$107.5K | -$470.1K | -$338.1K | |||
| Increase Decrease In Operating Lease Liability | -$58.0K | -$54.7K | ||||
| Proceeds From Issuance Or Sale Of Equity | $3.4M | $1.7M | ||||
| Proceeds From Issuance Of Common Stock | $25.0K | $25.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.8M | 896.4K | 12.7M | 3.1M | 1.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 1.8M | 896.4K | 12.7M | 3.1M | 1.2M |
| Earnings Per Share Diluted | $-3.71 | $-9.35 | $-0.66 | $-1.51 | $-0.53 |
| Earnings Per Share Basic | $-3.71 | $-9.35 | $-0.66 | $-1.51 | $-0.53 |
| Common Stock Shares Outstanding | 1.8M | 1.5M | 20.5M | 9.5M | 1.2M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 20.5M | 9.5M | 1.2M | ||
| Weighted Average Number Of Shares Outstanding Basic And Diluted | |||||
| Basic And Diluted Weighted Average Shares Outstanding Common Stock Attributable To Mana Capital Acquisition Corp. | |||||
| Basic And Diluted Net Loss Per Share Common Stock Attributable To Mana Capital Acquision Corp. | |||||
| Basic And Diluted Net Loss Per Share Common Stock Subject To Possible Redemption |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.8M | 1.7M | 1.7M | 814.8K | 753.6K | 702.6K | 11.9M | 10.2M | 9.5M | 6.6M | 5.4M | 4.2M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 1.8M | 1.7M | 1.7M | 814.8K | 753.6K | 702.6K | 11.9M | 10.2M | 9.5M | 6.6M | 5.4M | 4.2M | |||
| Earnings Per Share Diluted | $-0.98 | $-0.97 | $-0.97 | $-1.73 | $-1.71 | $-5.93 | $-0.16 | $-0.39 | $-0.11 | $-0.17 | $-0.16 | $-0.07 | |||
| Earnings Per Share Basic | $-0.98 | $-0.97 | $-0.97 | $-1.73 | $-1.71 | $-5.93 | $-0.16 | $-0.39 | $-0.11 | $-0.17 | $-0.16 | $-0.07 | |||
| Common Stock Shares Outstanding | 1.8M | 1.7M | 1.7M | 30.3M | 23.3M | 13.1M | 11.2M | 9.6M | 1.6M | 1.6M | 1.6M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $1.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Issued | 1.8M | 1.7M | 1.7M | 1.5M | 30.3M | 23.3M | 13.1M | 11.2M | 9.6M | 1.6M | 1.6M | 1.6M | |||
| Weighted Average Number Of Shares Outstanding Basic And Diluted | 6.5M | 6.5M | 6.5M | 0.00 | 0.00 | ||||||||||
| Basic And Diluted Weighted Average Shares Outstanding Common Stock Attributable To Mana Capital Acquisition Corp. | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | ||||||||||
| Basic And Diluted Net Loss Per Share Common Stock Attributable To Mana Capital Acquision Corp. | $0.02 | $-0.06 | $-0.14 | $0.00 | $0.00 | ||||||||||
| Basic And Diluted Net Loss Per Share Common Stock Subject To Possible Redemption | $0.02 | $-0.06 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Interest Income Operating | $712.00 | $1.1K | $1.1K | ||
| Additional Paid In Capital | $36.2M | $32.3M | $17.3M | $10.3M | $2.4M |
| Restricted Stock Awards Vested | $12.0K | $76.0K | $244.0K | ||
| Depreciation | $160.1K | $113.8K | $3.8K | $0.00 | |
| Depreciation And Amortization | $65.2K | $19.7K | $19.2K | $16.0K | $16.0K |
| Compensation For Vested Stock Options | $98.2K | $2.5M | $1.0M | ||
| Adjustment For Amortization | $238.1K | $162.6K | $107.8K | $16.0K | $16.0K |
| Interest Paid Net | $14.8K | $18.6K | $30.5K | $5.8K | $0.00 |
| Stock Issued During Period Value New Issues | $3.8M | $12.4M | $1.2M | ||
| Financing Agreement Entered Into For Prepaid Insurance | $337.2K | $383.5K | $467.5K | $1.0M | |
| Operating Costs And Expenses | |||||
| Franchise Tax Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Operating | $189.00 | $190.00 | $187.00 | $280.00 | $282.00 | $281.00 | $283.00 | $263.00 | $221.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid In Capital | $35.9M | $35.8M | $35.8M | $24.9M | $22.9M | $21.6M | $15.3M | $14.0M | $10.4M | $394.2K | $827.6K | $827.6K | ||
| Restricted Stock Awards Vested | $6.0K | $6.0K | $6.0K | $6.0K | $58.0K | $72.0K | $106.0K | $4.0K | ||||||
| Depreciation | $40.4K | $37.8K | $37.7K | $36.8K | $36.0K | $3.6K | $1.4K | $0.00 | $0.00 | |||||
| Depreciation And Amortization | $45.4K | $4.8K | $4.8K | $4.8K | $4.8K | $4.8K | $4.8K | $4.0K | $4.0K | $4.0K | ||||
| Compensation For Vested Stock Options | $24.8K | $24.8K | $24.6K | $16.6K | $20.7K | $2.5M | $1.0M | |||||||
| Adjustment For Amortization | $87.7K | $24.8K | $4.8K | $4.0K | ||||||||||
| Interest Paid Net | $4.7K | $5.8K | $8.9K | $0.00 | ||||||||||
| Stock Issued During Period Value New Issues | $116.6K | $3.4M | $2.0M | $1.3M | $1.7M | $25.0K | ||||||||
| Financing Agreement Entered Into For Prepaid Insurance | ||||||||||||||
| Operating Costs And Expenses | $115.3K | $448.6K | $177.1K | $721.00 | $397.00 | |||||||||
| Franchise Tax Expense | $50.0K | $50.0K | $50.0K | $0.00 | $0.00 |
Most recent annual filing with the SEC: March 13, 2026
Data sourced from SEC EDGAR public filings as of August 10, 2026.